Multidrug-resistant Candida auris: ‘new kid on the block’ in hospital-associated infections?

Journal of Hospital Infection

Volumn 94, Issue 3, 2016, Pages 209-212

  Chowdhary, A ^a   Voss, A ^b,c   Meis, J F ^b,c  

^a UNIVERSITY OF DELHI   (India)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Candida auris; Epidemiology; Identification; Infection prevention; Multidrug resistant

Indexed keywords

CANDIDA; EAR; HOSPITAL; INFECTION PREVENTION; KNOWLEDGE BASE; NONHUMAN; CANDIDIASIS; CLASSIFICATION; CROSS INFECTION; DRUG EFFECTS; HUMAN; INFECTION CONTROL; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PROCEDURES;

CANDIDA; CANDIDIASIS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, FUNGAL; HUMANS; INFECTION CONTROL;

EID: 84994764927     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2016.08.004     Document Type: Review

References (20)

1. 1 Brown, G.D., Denning, D.W., Gow, N.A., Levitz, S.M., Netea, M.G., White, T.C., Hidden killers: human fungal infections. Sci Transl Med, 4, 2012, 165rv13.
2. 2 Vincent, J.L., Rello, J., Marshall, J., et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302 (2009), 2323–2329.
3. 3 Pfaller, M.A., Andes, D.R., Diekema, D.J., et al. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the prospective antifungal therapy (PATH) registry 2004–2008. PLoS One, 9, 2014, e101510.
4. 4 Kulberg, B.J., Arendrup, M.C., Invasive candidiasis. N Engl J Med 373 (2015), 1445–1456.
5. 5 US Centers for Disease Control and Prevention. Global emergence of invasive infections caused by the multidrug-resistant yeast Candida auris. Available at: http://www.cdc.gov/fungal/diseases/candidiasis/candida-auris-alert.html [last accessed July 2016].
6. 6 Public Health England, Guidance for the laboratory investigation, management and infection prevention and control for cases of Candida auris. 2016 Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/534174/Guidance_Candida__auris.pdf [last accessed July 2016].
7. 7 Satoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., Yamaguchi, H., Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 53 (2009), 41–44.
8. 8 Lee, W.G., Shin, J.H., Uh, Y., et al. First three reported cases of nosocomial fungemia caused by. Candida auris. J Clin Microbiol 49 (2011), 3139–3142.
9. 9 Chowdhary, A., Sharma, C., Duggal, S., et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis 19 (2013), 1670–1673.
10. 10 Chowdhary, A., Anil Kumar, V., Sharma, C., et al. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis 33 (2014), 919–926.
11. 11 Girard, V., Mailler, S., Chetry, M., et al. Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry. Mycoses 59 (2016), 535–538.
12. 12 Emara, M., Ahmad, S., Khan, Z., et al. Candida auris candidemia in Kuwait, 2014. Emerg Infect Dis 21 (2015), 1091–1092.
13. 13 Calvo, B., Melo, A.S., Perozo-Mena, A., et al. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect 73 (2016), 369–374.
14. 14 Kathuria, S., Singh, P.K., Sharma, C., et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization–time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI Broth Microdilution, and Etest method. J Clin Microbiol 53 (2015), 1823–1830.
15. 15 Prakash, A., Sharma, C., Singh, A., et al. Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. Clin Microbiol Infect, 22, 2016, 277 e1–9.
16. 16 Sharma, C., Kumar, N., Pandey, R., Meis, J.F., Chowdhary, A., Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation. New Microbes New Infect 13 (2016), 77–82.
17. 17 Kumar, A., Prakash, A., Singh, A., et al. Candida haemulonii species complex: an emerging species in India and its genetic diversity assessed with multilocus sequence and amplified fragment-length polymorphism analyses. Emerg Microbes Infect, 5, 2016, e49.
18. 18 Sharma, C., Kumar, N., Meis, J.F., Pandey, R., Chowdhary, A., Draft genome sequence of a fluconazole-resistant Candida auris strain from a candidemia patient in India. Genome Announc, 3, 2015.
19. 19 Chatterjee, S., Alampalli, S.V., Nageshan, R.K., Chettiar, S.T., Joshi, S., Tatu, U.S., Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris. BMC Genomics, 16, 2015, 686.
20. 20 Boyce, J.M., Modern technologies for improving cleaning and disinfection of environmental surfaces in hospitals. Antimicrob Resist Infect Control, 5, 2016, 10.